Join today and have your say! It’s FREE!

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Please Try Again
{{ error }}
By providing my email, I consent to receiving investment related electronic messages from Stockhouse.

or

Sign In

Please Try Again
{{ error }}
Password Hint : {{passwordHint}}
Forgot Password?

or

Please Try Again {{ error }}

Send my password

SUCCESS
An email was sent with password retrieval instructions. Please go to the link in the email message to retrieve your password.

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.

Bullboard - Stock Discussion Forum Response Biomed Corp RPBIF

"Response Biomedical Corp is engaged in the research, development, commercialization and distribution of diagnostic technologies for the medical central-lab testing, point of care (POC) testing and on-site environmental testing markets."

GREY:RPBIF - Post Discussion

Response Biomed Corp > wow on about 100k over a number of days
View:
Post by thedave2006 on Jan 31, 2013 5:33pm

wow on about 100k over a number of days

run baby run, how goes it forum professors?  must of done a reverse split...again??

 

ps.  oh the sagas spun by jr companies and by forum professors......lol!!!!

 

cheers,

dave.

Comment by colonel44 on Feb 01, 2013 2:28pm
How high do we go to get even on reverse splits we had and recoup lost money  soon financials time and more promises..smart money follows. ANS..
Comment by yoshka2000 on Feb 06, 2013 2:36pm
So,what's up? Do they have any new contracts and sales for 2013 as of yet from our U.S. distributors ? Man that 20/1 rollback just about did me in.
Comment by dimar66 on Feb 26, 2013 4:33pm
It seems that gaining a position in the US market has a high priority, that is good because that is where the money is.  From today's press release: Response as we continue to solidify our plans to gain U.S. market share for our well-received product portfolio. This strategic hire comes on the heels of a successful U.S. FDA audit, the launch of the RAMP(R) 200 in the U.S. for use in ...more  
Comment by colonel44 on Mar 11, 2013 4:04pm
How many times have we heard this over the years and  look how much shareholders lost in the last five years.